SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950135-07-000844
Filing Date
2007-02-14
Accepted
2007-02-14 13:45:29
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL BIOTECH FUND L.P.RICHARD H. ALDRICH

Document Format Files

Seq Description Document Type Size
1 CHELSEA THERAPEUTICS INTERNATONAL, LTD. b64138clsc13gza.htm SC 13G/A 68062
  Complete submission text file 0000950135-07-000844.txt   70140
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81457 | Film No.: 07617692
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A